Dotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008, 83:511-519. Jongmans
Dotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008, 83:511-519. Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH: CHD7 mutations in patients initially diagnosed with Kallmann syndrome he clinical overlap with CHARGE syndrome. Clin Genet 2009, 75:65-71. Bianco SD, Kaiser UB: The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev AprotininMedChemExpress Aprotinin Endocrinol 2009, 5:569-576. Semple RK, Topaloglu AK: The recent genetics of hypogonadotrophic hypogonadism – novel insights and new questions. Clin Endocrinol (Oxf) 2010, 72:427-435. Miura K, Acierno JS Jr, Seminara SB: Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J Hum Genet 2004, 49:265-268. Miura K, Miura S, Yoshiura K, Seminara S, Hamaguchi D, Niikawa N, Masuzaki H: A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1. Hum Reprod 2010, 25:1076-1080. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE: Improving sequence variant descriptions in mutation databases and literature PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28914615 using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 2008, 29:6-13. Cheng A, McDonald NA, Connolly CN: Cell surface expression of 5hydroxytryptamine type 3 receptors is promoted by RIC-3. J Biol Chem 2005, 280:22502-22507. Ramensky V, Bork P, Sunyaev S: Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002, 30:3894-3900. Wincent J, Holmberg E, Stromland K, Soller M, Mirzaei L, Djureinovic T, Robinson K, Anderlid B, Schoumans J: CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. Clin Genet 2008, 74:31-38. Wincent J, Schulze A, Schoumans J: Detection of CHD7 deletions by MLPA in CHARGE syndrome patients with a less typical phenotype. Eur J Med Genet 2009, 52:271-272. Newberry EP, Boudreaux JM, Towler DA: The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGFselective transcriptional response motif. Mol Endocrinol 1996, 10:1029-1040. Verloes A: Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A 2005, 133A:306-308. Fromantin M, Gineste J, Didier A, Rouvier J: Impuberism and hypogonadism at induction into military service. Statistical study. Probl Actuels Endocrinol Nutr 1973, 16:179-199. Filippi G: Klinefelter’s syndrome in Sardinia. Clinical report of 265 hypogonadic males detected at the time of military check-up. Clin Genet 1986, 30:276-284. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Pinero A, Wolczynski S, Brailly-Tabard S, Bidet M, Ramos-Arroyo PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27488460 M, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dode C, Young J: A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab 2010, 95:659-669. Laitinen EM, Tommiska J, Dunkel L, Sankilampi U, Vaaralahti K, Raivio T: Idiopathic hypogonadotropic hypogonadism in a mother and her monozygotic twins born af.
Posted inUncategorized